SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

RBI examines Lupin’s proposal to increase FII limit to 49%

17 Oct 2013 Evaluate

The Reserve Bank of India (RBI) is studying the proposal submitted by Lupin for increasing the Foreign Institutional Investors (FIIs) shareholding limit from 33% to 49%. The company has applied to RBI for its approval pursuant to the resolution passed at the last Annual General Meeting (AGM) for the same.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2267.30 -110.60 (-4.65%)
11-May-2026 12:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.20
Dr. Reddys Lab 1295.65
Cipla 1314.50
Zydus Lifesciences 943.65
Lupin 2267.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×